Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic renal allograft dysfunction.

Jeremy R Chapman1, Philip J O'Connell, Brian J Nankivell

  • 1Department of Renal Medicine, Westmead Hospital, Westmead, New South Wales 2145, Australia. jeremy_chapman@wsahs.nsw.gov.au

Journal of the American Society of Nephrology : JASN
|August 27, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Diversity of Transplant Glomerulitis and its Relationship to Alloantibody.

Kidney international reports·2026
Same author

Deceased Organ Donation and Transplantation in LIMC: A Meeting Report.

Transplantation·2026
Same author

BEAT-BK: An Adaptive, Randomized Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney-pancreas Transplantation Recipients (BEAT-BK) Study Protocol.

Transplantation direct·2026
Same author

Longitudinal Assessment of Health-Related Quality of Life in Adults with CKD.

Kidney360·2025
Same author

Enhanced Diagnosis of Chronic Antibody-mediated Rejection Using Peritubular Capillary Multilayering.

Transplantation·2025
Same author

The Accuracy of Blood Nucleic Acid Testing to Predict BK Polyomavirus Nephropathy Varies by Clinical Context.

Transplantation direct·2025

Chronic allograft nephropathy (CAN) leads to kidney transplant loss through fibrosis and damage. Early detection is crucial, as current methods identify it too late for effective intervention, often resulting in graft failure.

Area of Science:

  • Nephrology
  • Transplant Immunology
  • Pathology

Background:

  • Renal transplant loss is primarily caused by vascular, malignant, infectious diseases, or chronic renal dysfunction.
  • Chronic allograft nephropathy (CAN) describes graft fibrosis and damage, a major contributor to long-term allograft failure.
  • Current monitoring of serum creatinine changes for CAN is often a late indicator, underestimating disease severity.

Purpose of the Study:

  • To highlight the limitations of current diagnostic methods for chronic allograft nephropathy (CAN).
  • To discuss the causes and progression of CAN, including ischemia-reperfusion injury, rejection, and calcineurin inhibitor nephrotoxicity.
  • To review treatment strategies for CAN, focusing on minimizing calcineurin inhibitor use.

Main Methods:

Related Experiment Videos

  • Review of existing literature on renal transplant outcomes and chronic allograft nephropathy.
  • Analysis of the causes and histological features of CAN.
  • Evaluation of current and proposed immunosuppression strategies for preventing CAN.

    • Main Results:

    • Late detection of CAN via serum creatinine monitoring hinders timely intervention.
    • CAN progresses from interstitial fibrosis and arteriolar hyalinosis to glomerulosclerosis.
    • Immunosuppression strategies avoiding calcineurin inhibitors show promise but are often implemented too late.

    Conclusions:

    • Effective management of renal allografts requires earlier identification of chronic allograft nephropathy (CAN).
    • Current treatment strategies are often initiated too late to prevent significant graft dysfunction and loss.
    • Further research into early diagnostic markers and proactive interventions for CAN is essential.